Ligne de temps
Jamie Sugrue
Post-doctorant(e)
14 sept. 2025
publication
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.
Lire plus01 sept. 2025
publication
Altered DNA methylation of the ABO gene is associated with differential plasma levels of von willebrand factor and E‐selectin
Lire plus28 mars 2025
01 sept. 2024
07 mars 2024
01 févr. 2023
25 nov. 2022
publication
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Lire plus15 nov. 2022
publication
Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort.
Lire plus28 juin 2022
publication
Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation.
Lire plus15 avr. 2022
publication
Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus.
Lire plus01 avr. 2022
publication
Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression.
Lire plus28 févr. 2022
publication
Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort.
Lire plus01 janv. 2021
publication
Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.
Lire plus02 juil. 2020
01 janv. 2020
publication
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.
Lire plus01 avr. 2019
11 mars 2019
publication